Overexpression of Kinase-Negative Protein Kinase Cδ in Pancreatic β-Cells Protects Mice From Diet-Induced Glucose Intolerance and β-Cell Dysfunction
- Anita M. Hennige1,
- Felicia Ranta1,
- Isabel Heinzelmann1,
- Martina Düfer2,
- Diana Michael1,
- Heidi Braumüller3,
- Stefan Z. Lutz1,
- Reiner Lammers1,
- Gisela Drews2,
- Fatima Bosch4,
- Hans-Ulrich Häring1 and
- Susanne Ullrich1
- 1Department of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Medicine, Nephrology, and Clinical Chemistry, University of Tübingen, Tübingen, Germany;
- 2Department of Pharmacology and Toxicology, Institute of Pharmacy, University of Tübingen, Tübingen, Germany;
- 3Department of Dermatology, University of Tübingen, Tübingen, Germany;
- 4Center of Animal Biotechnology and Gene Therapy, Universita Autònoma Barcelona, and CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain.
- Corresponding author: Susanne Ullrich, susanne.ullrich{at}med.uni-tuebingen.de.
-
A.M.H. and F.R. contributed equally to this study.
Abstract
OBJECTIVE In vitro models suggest that free fatty acid–induced apoptotic β-cell death is mediated through protein kinase C (PKC)δ. To examine the role of PKCδ signaling in vivo, transgenic mice overexpressing a kinase-negative PKCδ (PKCδKN) selectively in β-cells were generated and analyzed for glucose homeostasis and β-cell survival.
RESEARCH DESIGN AND METHODS Mice were fed a standard or high-fat diet (HFD). Blood glucose and insulin levels were determined after glucose loads. Islet size, cleaved caspase-3, and PKCδ expression were estimated by immunohistochemistry. In isolated islet cells apoptosis was assessed with TUNEL/TO-PRO3 DNA staining and the mitochondrial potential by rhodamine-123 staining. Changes in phosphorylation and subcellular distribution of forkhead box class O1 (FOXO1) were analyzed by Western blotting and immunohistochemistry.
RESULTS PKCδKN mice were protected from HFD-induced glucose intolerance. This was accompanied by increased insulin levels in vivo, by an increased islet size, and by a reduced staining of β-cells for cleaved caspase-3 compared with wild-type littermates. In accordance, long-term treatment with palmitate increased apoptotic cell death of isolated islet cells from wild-type but not from PKCδKN mice. PKCδKN overexpression protected islet cells from palmitate-induced mitochondrial dysfunction and inhibited nuclear accumulation of FOXO1 in mouse islet and INS-1E cells. The inhibition of nuclear accumulation of FOXO1 by PKCδKN was accompanied by an increased phosphorylation of FOXO1 at Ser256 and a significant reduction of FOXO1 protein.
CONCLUSIONS Overexpression of PKCδKN in β-cells protects from HFD-induced β-cell failure in vivo by a mechanism that involves inhibition of fatty acid–mediated apoptosis, inhibition of mitochondrial dysfunction, and inhibition of FOXO1 activation.
Footnotes
-
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
See accompanying commentary, p. 1.
-
- Received April 7, 2009.
- Accepted September 15, 2009.
- © 2010 American Diabetes Association











